|
2026
|
G/S
|
Pharmaceutical preparations. |
|
2025
|
G/S
|
Mobile Apps in the medical field; Software for analytics in the fields of public health, healthca... |
|
|
G/S
|
Pharmaceutical preparations for use in neuroscience. |
|
|
G/S
|
Préparations pharmaceutiques destinées au domaine des neurosciences. |
|
|
Invention
|
Automated solid-state amplification of library constructs for duplex sequencing. The present inve... |
|
|
Invention
|
Nickase-mediated linear amplification of library constructs for duplex sequencing. The present in... |
|
|
Invention
|
Process for the preparation of 2-(3-cyano-5-fluorophenyl)-2-methyl-propionic acid. The invention ... |
|
|
Invention
|
Synthesis of an intermediate and its use for the preparation of glp-1r/gipr agonists. The inventi... |
|
|
Invention
|
Synthesis of glp-1r/gipr agonists. The present disclosure provides novel synthetic methods for pr... |
|
|
Invention
|
Methods for correcting a dc current, recorded by an amperometric sensor in contact with a medical... |
|
|
Invention
|
Device for holding and stationary mounting at least one medical container. The invention relates ... |
|
|
Invention
|
Solid forms of ras inhibitor. rRSNSMSS)-1-methoxyethyl]-5-(4-methylpiperazin-1-yl)-3- pyridyl]-17... |
|
|
Invention
|
Processes for manufacturing biaryl thioethers. 144-carbamate; and R2 is a halogen atom selected f... |
|
|
Invention
|
Anti-gastrin antibodies and uses thereof. The present invention provides for monoclonal antibodie... |
|
|
Invention
|
Ras inhibitors in combination therapy for use in treating cancers. The present invention relates ... |
|
|
Invention
|
Novel aav rep orfs and rep polypeptides. Herein is reported a nucleic acid encoding a functional ... |
|
|
Invention
|
In-vitro diagnostics sensing system and in-vitro diagnostics sensing method of determining a pres... |
|
|
Invention
|
Process for preparing btk inhibitor intermediates. Crystalline forms of intermediate compound (19... |
|
|
Invention
|
Combinations comprising a kras g12c inhibitor, pembrolizumab and a steroid. Provided herein are m... |
|
|
Invention
|
Novel formulations for oral administration of oligonucleotides. The present invention provides no... |
|
|
Invention
|
Pipetting tip, tip arrangement, liquid handling system and method for illuminating a biological s... |
|
|
Invention
|
Zifibancimig for use in methods for treating ocular diseases. The present invention relates to to... |
|
|
Invention
|
Zifibancimig for use in methods for treating ocular diseases via an ocular implant. The present i... |
|
|
Invention
|
Palladium catalyzed synthesis of aminoaldehyde intermediates. Provided herein are processes for t... |
|
|
Invention
|
Methods of treating cancer using subcutaneous dosing of mosunetuzumab as a monotherapy or in comb... |
|
|
Invention
|
Generating motor enhanced and de-identified video data from a patient video and generating a trai... |
|
|
Invention
|
Method for determining empty, partially filled and full recombinant aav particles. Herein is repo... |
|
|
Invention
|
Dihydro benzoxazine derivatives. The invention provides new heterocyclic compounds having the gen... |
|
|
Invention
|
Anti-cancer combinations comprising mosperafenib and folfox or folfiri. Provided herein are combi... |
|
|
Invention
|
Macrocyclic compounds for the treatment of cancer. The present invention relates to compounds of ... |
|
|
Invention
|
Methods of using a bispecific antibody that recognizes coagulation factor ix and/or activated coa... |
|
|
Invention
|
Triazine derivatives. The invention relates to novel compounds having the general formula (I) whe... |
|
|
Invention
|
Use of atr inhibitors in combination with radioligand therapy for the treatment of cancer. Disclo... |
|
|
Invention
|
Hydroxyl compounds targeting the ccr6 receptor. The present invention provides new derivatives ha... |
|
|
Invention
|
Method for purifying plasmid dna. Herein is reported a method for producing a recombinant plasmid... |
|
|
Invention
|
Implicitly guided generation by matching data points.
An input molecule exhibiting a value for o... |
|
|
Invention
|
Iterative training with pseudo-matched molecule pairs for machine learning enabled enhancement of... |
|
|
Invention
|
Machine learning enabled enhancement of molecular properties. An input molecule exhibiting a valu... |
|
|
Invention
|
Machine learning enabled enhancement of molecular properties.
An input molecule exhibiting a val... |
|
|
Invention
|
Structure-informed machine learning enabled enhancement of molecular properties.
An input molecu... |
|
|
Invention
|
Method for generating spinal cord synthetic mri data. The present invention concern the field of ... |
|
|
Invention
|
Test kit for determining analytes in a sample of a bodily fluid. A test kit (110), a test strip (... |
|
|
Invention
|
Methods for treatment of inflammatory bowel disease with an anti-tl1a antibody. The present discl... |
|
|
Invention
|
Three-dimensional molecule generation. A method for generating an output molecule may include det... |
|
|
Invention
|
Recombinant binding proteins with conditionally activatable t cell and nk cell recruiting effecto... |
|
|
Invention
|
Assay for detection of mutations conferring resistance to treatment with an immunotherapeutic age... |
|
|
Invention
|
Antigen binding molecules. The present invention relates to a pair of binding molecules comprisin... |
|
|
Invention
|
Device for determining a fill level of a liquid in a container, apparatus, system and method. The... |
|
|
Invention
|
Recombinant fc domain – il7 variant polypeptides and combination therapy with membrane-anchored a... |
|
|
Invention
|
Pharmacodynamics modelling. in vivo in vitroin vivoin vivo level profile for each of said one or ... |
|
|
Invention
|
Use of atr inhibitors in combination with anti-pd(l)1 therapy. Disclosed are methods of treating ... |
|
|
Invention
|
Dose regimen for a 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,... |
|
|
G/S
|
Préparations pharmaceutiques destinées à être utilisées en neurosciences. |
|
2024
|
G/S
|
Préparations pharmaceutiques destinées à l'oncologie. |
|
|
G/S
|
Préparations pharmaceutiques destinées à immunologie; préparations pharmaceutiques pour le traite... |
|
|
G/S
|
Préparations pharmaceutiques destinées à l'immunologie; Préparations pharmaceutiques pour le trai... |
|
|
G/S
|
Ophthalmological equipment and instruments. |
|
|
G/S
|
Préparations pharmaceutiques destinées à l'ophtalmologie. |
